Health Literacy for Children With Atopic Dermatitis and Their Caregivers
- Conditions
- Atopic Dermatitis
- Registration Number
- NCT01138761
- Lead Sponsor
- University of Missouri-Columbia
- Brief Summary
The purpose of this study is to determine the effectiveness of additional nursing instruction for the caregivers of newly diagnosed pediatric atopic dermatitis patients at the University of Missouri Dermatology clinic.
- Detailed Description
The purpose of this study is to determine the effectiveness of additional nursing instruction for the caregivers of newly diagnosed pediatric atopic dermatitis patients at the University of Missouri Dermatology clinic. Caregivers of children with atopic dermatitis will be randomized to one of two instruction/education procedures. The goal is to determine if improved retention of information by caregivers/parents of children with atopic dermatitis is associated with better patient outcomes.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 33
- New clinical diagnosis of pediatric atopic dermatitis, or existing atopic dermatitis but new patient to MU dermatology
- Age 7 or under
- Age 8 or above
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Eczema Area and Severity Index (EASI) EASI administered by blinded investigator at the initial visit, prior to teaching intervention; EASI again administered by same blinded investigator at visit 2 (at 4 weeks). The Eczema Area and Severity Index is used to document extent and severity of atopic dermatitis on child's skin at the beginning of the study and again at the follow-up visit. The purpose is to determine improvement or lack of improvement following teaching intervention by nurses in the dermatology clinic.
- Secondary Outcome Measures
Name Time Method Caregiver Questionnaire Visit 2 (or Week 4 visit) A 27 item written questionnaire will be given to the parent/caregiver at visit 2. This questionnaire tests the retention of information given at visit 1 to subjects in both arms of the study (treatment and control group).
Trial Locations
- Locations (1)
University of Missouri Dermatology Clinic
🇺🇸Columbia, Missouri, United States
University of Missouri Dermatology Clinic🇺🇸Columbia, Missouri, United States